Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorHorozoğlu, Fatih
dc.contributor.authorGönen, Tansu
dc.contributor.authorYaşar, Mustafa
dc.contributor.authorSever, Özkan
dc.contributor.authorKeskinbora, Kadircan Hıdır
dc.date.accessioned2022-05-11T14:35:46Z
dc.date.available2022-05-11T14:35:46Z
dc.date.issued2013
dc.identifier.issn1300-0659
dc.identifier.issn2147-2661
dc.identifier.urihttps://doi.org/10.4274/tjo.82621
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8210
dc.description.abstractPurpose: To compare the corneal endothelial changes after injection of a single-dose intravitreal bevacizumab or intravitreal ranibizumab. Material and Method: In this retrospective study, we evaluated 27 eyes of 27 patients with either diabetic macular edema or senile macular degeneration, who underwent 1.25 mg/0.05 ml intravitreal bevacizumab or 0.5 mg/0.05 ml ranibizumab injection. None of the patients had corneal pathology. Fourteen eyes of 14 patients received intravitreal ranibizumab, other 13 eyes of 13 patients received intravitreal bevacizumab. We evaluated preoperative and postoperative 1st week and 1st month visual acuity, corneal endothelial count at mm(2), intraocular pressure, and pachymetry results. For statistical analysis, Mann-Whitney U and Wilcoxon tests were used. Results: Mean age of the patients was 69.3 +/- 12.5 (44-85 year). Average corneal endothelial cell count for bevacizumab and ranibizumab was preoperatively 2358.1 +/- 487 and 2348.9 +/- 598, postoperative 1. week 2360.8 +/- 474.1 and 2398.3 +/- 585.6, postoperative 1. month 2315.1 +/- 465 and 2407.4 +/- 585.6, respectively. Preoperative and postoperative corneal endothelial cell counts were not statistically significantly different in both groups (respectively, 1. week p=0.953 and p=0.59; 1. month p=0.26 and p=0.555). Average central macular thickness for bevacizumab and ranibizumab was preoperatively 527.3 +/- 36.9 and 544.1 +/- 55.5 mu m, postoperative 1. week 529.2 +/- 49.9 and 543.5 +/- 51.8 mu m, postoperative 1. month 530.3 +/- 55 and 543.9 +/- 46.6 mu m, respectively. Preoperative and postoperative central macular thickness values for both groups were not statistically significantly different (respectively, 1. week P=0.515 and P=0.838; 1. month P=0.678 and P=0.444). Discussion: Injection of a single dose of 1.25 mg/0.05 ml bevacizumab or 0.5 mg/0.05 ml ranibizumab does not affect the corneal endothelial cell count at 1. week and 1. month.en_US
dc.language.isoturen_US
dc.publisherTurkish Ophthalmological Socen_US
dc.identifier.doi10.4274/tjo.82621
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBevacizumaben_US
dc.subjectranibizumaben_US
dc.subjectintravitrealen_US
dc.subjectcorneaen_US
dc.titleComparison of Corneal Endothelial Changes After a Single-Dose Injection of Bevacizumab or Ranibizumaben_US
dc.title.alternativeİntravitreal bevacizumab veya ranibizumab enjeksiyonu yapi{dotless}lan olgularda kornea endotelindeki de?işimin karşi{dotless}laşti{dotless}ri{dotless}lmasi{dotless}]en_US
dc.typearticleen_US
dc.relation.ispartofTurk Oftalmoloji Dergisi-Turkish Journal of Ophthalmologyen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume43en_US
dc.identifier.issue6en_US
dc.identifier.startpage391en_US
dc.identifier.endpage394en_US
dc.institutionauthorHorozoğlu, Fatih
dc.institutionauthorGönen, Tansu
dc.institutionauthorYaşar, Mustafa
dc.institutionauthorSever, Özkan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid9733109900
dc.authorscopusid34869701000
dc.authorscopusid50263803900
dc.authorscopusid50263136900
dc.authorscopusid55913025800
dc.authorwosidKeskinbora, Kadircan/AAM-6453-2020
dc.authorwosidHorozoglu, Fatih/AAM-4273-2021
dc.identifier.wosWOS:000219219300004en_US
dc.identifier.scopus2-s2.0-84894544134en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster